BackSingular Genomics Systems Overview

Singular Genomics Systems Other Current Assets

Singular Genomics Systems's other current assets is $3.4M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$3.38M
907.14% YoYΔ $3.05M vs prior year quarter

Peer average

Loading

Singular Genomics Systems Other Current Assets History

Loading

Singular Genomics Systems vs. peers: Other Current Assets Comparison

Loading

Singular Genomics Systems Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Singular Genomics Systems (OMIC) FAQ

Singular Genomics Systems (OMIC) currently reports a other current assets of $3.4M as of September 2024. That compares with $340K in the prior-year period — up 907.1% year over year. Use the charts on this page to explore Singular Genomics Systems's other current assets history and peer comparisons.

Singular Genomics Systems's other current assets increased from $340K to $3.4M — a 907.1% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Singular Genomics Systems reported $3.4M in other current assets as of September 2024. That compares with $340K in the prior-year period — up 907.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $3.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Singular Genomics Systems, and consider following OMIC for alerts when major investors trade the stock.

Singular Genomics Systems is classified in the Healthcare sector. On other current assets, it currently shows $3.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OMIC with unrelated industries.